- 专利标题： AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF
-
申请号： PCT/US2018/041612申请日： 2018-07-11
-
公开(公告)号： WO2019014328A3公开(公告)日： 2019-01-17
- 发明人: BOBROWICZ, Piotr , WIDBOOM, Paul , SCHMIDT, Michael, March , LAJOIE, Jason, M. , TIGHE, Robert, V., III , LEUNG, Cheuk, Lun , ESKIOCAK, Ugur
- 申请人： COMPASS THERAPEUTICS LLC
- 申请人地址： 245 First Street, Third Floor Cambridge, MA 02142 US
- 专利权人： COMPASS THERAPEUTICS LLC
- 当前专利权人： COMPASS THERAPEUTICS LLC
- 当前专利权人地址： 245 First Street, Third Floor Cambridge, MA 02142 US
- 代理机构： MANDRAGOURAS, Amy, E. et al.
- 优先权： US62/531,259 20170711; US62/568,231 20171004; US62/531,190 20170711; US62/577,257 20171026; US62/577,259 20171026
- 主分类号： C07K16/28
- IPC分类号： C07K16/28
摘要：
The present disclosure relates to, inter alia , compounds (e.g., antibodies, or antigen-binding fragments thereof) that bind to an epitope of CD137 and agonize CD137, and to use of the compounds in methods for treating, or ameliorating one or more symptoms of, cancer.
公开/授权文献
- WO2019014328A2 AGONIST ANTIBODIES THAT BIND HUMAN CD137 AND USES THEREOF 公开/授权日：2019-01-17
